Literature DB >> 27109195

Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles.

Chuntang Sun1, Le Zhou2, Maling Gou3, Shuai Shi4, Tao Li1, Jinyi Lang1.   

Abstract

Doxorubicin (Dox) is a broad-spectrum antitumor drug used for the treatment of many types of malignant tumors. Although it possesses powerful antitumor activity, its clinical application is seriously encumbered by its unselective distribution and systemic toxicities, particularly myocardial toxicity. Thus, it is imperative to modify Dox to decrease its systemic toxicities and improve its therapeutic index. In the present study, we adopted a novel type of monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) (MPEG-PCL) micelles to encapsulate Dox to prepare Dox-loaded MPEG-PCL (Dox/MPEG-PCL) nanoparticles by a controllable self-assembly process. The cellular uptake efficiency and cell proliferation inhibition of the Dox/MPEG-PCL nanoparticles were examined. The antitumor activity of the Dox/MPEG-PCL nanoparticles was tested on a multiple pulmonary metastasis model of melanoma on C57BL/6 mice. Systemic toxicities and survival time were compared between the mice treated with the Dox/MPEG-PCL nanoparticles and free Dox. The potential myocardial toxicity of the Dox/MPEG-PCL nanoparticles was investigated using a prolonged observation period. Encapsulation of Dox in MPEG-PCL nanoparticles significantly improved the cellular uptake and cell proliferation inhibition of Dox in vivo. Intravenous injection of Dox/MPEG-PCL nanoparticles obtained significant inhibition of the growth and metastasis of melanoma in the lung and prolonged survival time compared with free Dox (P<0.05). The Dox/MPEG-PCL nanoparticles did not show obvious additional systemic toxicities compared with free Dox during the treatment time. During the prolonged observation period, obvious decreased cardiac toxicity was observed in the Dox/MPEG-PCL nanoparticle-treated mice compared with that observed in the free Dox-treated mice. These results indicated that encapsulating Dox with MPEG-PCL micelles could significantly promote its antitumor activity and reduce its toxicity to the myocardium.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27109195     DOI: 10.3892/or.2016.4748

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Autocatalytic Delivery of Brain Tumor-targeting, Size-shrinkable Nanoparticles for Treatment of Breast Cancer Brain Metastases.

Authors:  Shenqi Zhang; Gang Deng; Fuyao Liu; Bin Peng; Youmei Bao; Fengyi Du; Ann T Chen; Jun Liu; Zeming Chen; Junning Ma; Xiangjun Tang; Qianxue Chen; Jiangbing Zhou
Journal:  Adv Funct Mater       Date:  2020-02-20       Impact factor: 18.808

2.  Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity.

Authors:  Ashita Nair; Jiyoon Bu; Piper A Rawding; Steven C Do; Hangpeng Li; Seungpyo Hong
Journal:  Nanomaterials (Basel)       Date:  2021-12-21       Impact factor: 5.076

3.  In vitro chemosensitivity of a canine tumor venereal transmissible cancer cell line.

Authors:  Moisés Armides Franco Molina; Edson Antonio Santamaría-Martínez; Silvia Elena Santana Krimskaya; Diana Ginette Zarate-Triviño; Jorge R Kawas; Yareellys Ramos Zayas; Natanael Palacios Estrada; Heriberto Prado García; Paola Leonor García Coronado; Cristina Rodríguez Padilla
Journal:  Front Vet Sci       Date:  2022-08-18

4.  Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy.

Authors:  Xichuan Tang; Liwei Tan; Kun Shi; Jinrong Peng; Yao Xiao; Wenting Li; Lijuan Chen; Qian Yang; Zhiyong Qian
Journal:  Acta Pharm Sin B       Date:  2018-06-05       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.